Long non-coding RNA HOXA-AS3 promotes cell proliferation of oral squamous cell carcinoma through sponging microRNA miR-218-5p

References

• Nagao T, Warnakulasuriya S. Screening for oral cancer: future prospects, research and policy development for Asia. Oral Oncol. 2020;105:104632.
   PubMed Web of Science ®Google Scholar
• Shrestha AD, Vedsted P. Prevalence and incidence of oral cancer in low- and middle-income countries: a scoping review. Eur J Cancer Care (Engl). 2020;29(2):e13207.
   Google Scholar
• Almangush A, Mäkitie AA, Triantafyllou A, et al. Staging and grading of oral squamous cell carcinoma: an update. Oral Oncol. 2020;107:104799.
   PubMed Web of Science ®Google Scholar
• Wang W, Adeoye J, Thomson P. Statistical profiling of oral cancer and the prediction of outcome. J Oral Pathol Med. 2021;50(1):39–46.
   Google Scholar
• Zhang X, Cui Y, Ding X, et al. Analysis of mRNA‑lncRNA and mRNA‑lncRNA-pathway co‑expression networks based on WGCNA in developing pediatric sepsis. Bioengineered. 2021;12(1):1457–1470.
   PubMed Web of Science ®Google Scholar
• Jiang L, Ge W, Cui Y, et al. The regulation of long non-coding RNA 00958 (LINC00958) for oral squamous cell carcinoma (OSCC) cells death through absent in melanoma 2 (AIM2) depending on microRNA-4306 and Sirtuin1 (SIRT1) in vitro. Bioengineered. 2021;12(1):5085–5098.
   PubMed Web of Science ®Google Scholar
• Feng J, Li J, Qie P, et al. Long non-coding RNA (lncRNA) PGM5P4-AS1 inhibits lung cancer progression by up-regulating leucine zipper tumor suppressor (LZTS3) through sponging microRNA miR-1275. Bioengineered. 2021;12(1):196–207.
   PubMed Web of Science ®Google Scholar
• Long H, Li Q, Xiao Z, et al. LncRNA MIR22HG promotes osteoarthritis progression via regulating miR-9-3p/ADAMTS5 pathway. Bioengineered. 2021;12(1):3148–3158.
   PubMed Web of Science ®Google Scholar
• Momen-Heravi F, Bala S. Emerging role of non-coding RNA in oral cancer. Cell Signal. 2018;42:134–143.
   PubMed Web of Science ®Google Scholar
• Tao D, Zhang Z, Liu X, et al. LncRNA HOTAIR promotes the invasion and metastasis of oral squamous cell carcinoma through metastasis-associated gene 2. Mol Carcinog. 2020;59(4):353–364.
   Google Scholar
• Li X, Ma C, Zhang L, et al. LncRNAAC132217.4, a KLF8-regulated long non-coding RNA, facilitates oral squamous cell carcinoma metastasis by upregulating IGF2 expression. Cancer Lett. 2017;407:45–56.
   PubMed Web of Science ®Google Scholar
• Huang G, He X, Wei XL. lncRNA NEAT1 promotes cell proliferation and invasion by regulating miR‑365/RGS20 in oral squamous cell carcinoma. Oncol Rep. 2018;39(4):1948–1956.
   PubMed Web of Science ®Google Scholar
• Wang J, Huo F, Wang X-R, et al. LncRNA LACAT1 promotes proliferation of oral squamous cell carcinoma cells by inhibiting microRNA-4301. Eur Rev Med Pharmacol Sci. 2019;23(6):2427–2435.
   PubMed Web of Science ®Google Scholar
• Lin S, Zhang R, An X, et al. LncRNA HOXA-AS3 confers cisplatin resistance by interacting with HOXA3 in non-small-cell lung carcinoma cells. Oncogenesis. 2019;8(11):60.
   PubMedGoogle Scholar
• Tong Y, Wang M, Dai Y, et al. LncRNA HOXA-AS3 sponges miR-29c to facilitate cell proliferation, metastasis, and EMT process and activate the MEK/ERK signaling pathway in hepatocellular carcinoma. Cancer Cell Int. 2019;30(3):129–141.
   Google Scholar
• Chen W, Li Q, Zhang G, et al. LncRNA HOXA-AS3 promotes the malignancy of glioblastoma through regulating miR-455-5p/USP3 axis. J Cell Mol Med. 2020;24(20):11755–11767.
   Google Scholar
• Qu F, Zhu B, Hu YL, et al. LncRNA HOXA-AS3 promotes gastric cancer progression by regulating miR-29a-3p/LTβR and activating NF-κB signaling. J Cell Mol Med. 2021;21(1):118.
   Google Scholar
• Zhang N, Liu JF. MicroRNA (MiR)-301a-3p regulates the proliferation of esophageal squamous cells via targeting PTEN. Bioengineered. 2020;11(1):972–983.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Zhang Y, Wang S, et al. SP1-induced lncRNA ZFPM2 antisense RNA 1 (ZFPM2-AS1) aggravates glioma progression via the miR-515-5p/Superoxide dismutase 2 (SOD2) axis. Bioengineered. 2021;12(1):2299–2310.
   Google Scholar
• Li JH, Liu S, Zhou H, et al. starBase v2.0: decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA interaction networks from large-scale CLIP-Seq data. Nucleic Acids Res. 2014;42( Database issue):D92–7.
   PubMed Web of Science ®Google Scholar
• He B, Lin X, Tian F, et al. MiR-133a-3p inhibits oral squamous cell carcinoma (OSCC) proliferation and invasion by suppressing COL1A1. J Cell Biochem. 2018;119(1):338–346.
   PubMed Web of Science ®Google Scholar
• Shida-Sakazume T, Endo-Sakamoto Y, Unozawa M, et al. Lysophosphatidylcholine acyltransferase1 overexpression promotes oral squamous cell carcinoma progression via enhanced biosynthesis of platelet-activating factor. PLoS One. 2015;10(3):e0120143.
   PubMed Web of Science ®Google Scholar
• Bagan J, Sarrion G, Jimenez Y. Oral cancer: clinical features. Oral Oncol. 2010;46(6):414–417.
   PubMed Web of Science ®Google Scholar
• Anal Cell Pathol (Amst).
   Google Scholar
• Thomson PJ. Perspectives on oral squamous cell carcinoma prevention-proliferation, position, progression and prediction. J Oral Pathol Med. 2018;47(9):803–807.
   PubMed Web of Science ®Google Scholar
• Chai AWY, Lim KP, Cheong SC. Translational genomics and recent advances in oral squamous cell carcinoma. Semin Cancer Biol. 2020;61:71–83.
   PubMed Web of Science ®Google Scholar
• Li L, Wang Y, Song G, et al. HOX cluster-embedded antisense long non-coding RNAs in lung cancer. Cancer Lett. 2019;450:14–21.
   PubMed Web of Science ®Google Scholar
• Zhu XX, Yan Y-W, Chen D, et al. Correction: long non-coding RNA HoxA-AS3 interacts with EZH2 to regulate lineage commitment of mesenchymal stem cells. Oncotarget. 2018;9(25):17978.
   PubMedGoogle Scholar
• Tong Y, Wang M, Dai Y, et al. LncRNA HOXA-AS3 sponges miR-29c to facilitate cell proliferation, metastasis, and EMT process and activate the MEK/ERK signaling pathway in hepatocellular carcinoma. Hum Gene Ther Clin Dev. 2019;30(3):129–141.
   PubMed Web of Science ®Google Scholar
• Chen D, Xie S, Wu Y, et al. Reduction of bladder cancer chemosensitivity induced by the effect of HOXA-AS3 as a ceRNA for miR-455-5p that upregulates notch1. Front Oncol. 2020;10:572672.
   PubMed Web of Science ®Google Scholar
• Qu F, Zhu B, Hu YL, et al. LncRNA HOXA-AS3 promotes gastric cancer progression by regulating miR-29a-3p/LTβR and activating NF-κB signaling. Biochem Genet. 2021;21(1):118.
   Google Scholar
• Wu F, Zhang C, Cai J, et al. Upregulation of long noncoding RNA HOXA-AS3 promotes tumor progression and predicts poor prognosis in glioma. Cancer Cell Int. 2017;8(32):53110–53123.
   Google Scholar
• Zhang H, Liu Y, Yan L, et al. Increased levels of the long noncoding RNA, HOXA-AS3, promote proliferation of A549 cells. Cell Death Dis. 2018;9(6):707.
   PubMedGoogle Scholar
• Li L, Yu H, Ren Q. MiR-218-5p suppresses the progression of retinoblastoma through targeting NACC1 and inhibiting the AKT/mTOR signaling pathway. Cancer Manag Res. 2020;12:6959–6967.
   PubMed Web of Science ®Google Scholar
• Xu Y, He Q, Lu Y, et al. MicroRNA-218-5p inhibits cell growth and metastasis in cervical cancer via LYN/NF-κB signaling pathway. Cancer Gene Ther. 2018;18:198.
   Google Scholar
• Deng M, Zeng C, Lu X, et al. miR-218 suppresses gastric cancer cell cycle progression through the CDK6/Cyclin D1/E2F1 axis in a feedback loop. Cancer Lett. 2017;403:175–185.
   PubMed Web of Science ®Google Scholar
• Wu Z, Han Y, Li Y, et al. MiR-218-5p inhibits the stem cell properties and invasive ability of the A2B5⁺CD133⁻ subgroup of human glioma stem cells. Cancer Cell Int. 2016;35(2):869–877.
   Google Scholar
• Li X, He J, Shao M, et al. Downregulation of miR-218-5p promotes invasion of oral squamous cell carcinoma cells via activation of CD44-ROCK signaling. Biomed Pharmacother. 2018;106:646–654.
   PubMed Web of Science ®Google Scholar
• Liu J, Shen JX, Wu HT, et al. Collagen 1A1 (COL1A1) promotes metastasis of breast cancer and is a potential therapeutic target. Discov Med. 2018;25(139):211–223.
   PubMed Web of Science ®Google Scholar
• Spenlé C, Loustau T, Murdamoothoo D, et al. Tenascin-C orchestrates an immune-suppressive tumor microenvironment in oral squamous cell carcinoma. Cancer Immunol Res. 2020;8(9):1122–1138.
   Google Scholar